Westfield Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.4M | Sell |
1,259,376
-175,394
| -12% | -$8.28M | 0.25% | 123 |
|
|
2025
Q1 | $56.1M | Buy |
1,434,770
+123,151
| +9% | +$4.81M | 0.27% | 115 |
|
|
2024
Q4 | $71M | Buy |
1,311,619
+144,261
| +12% | +$7.81M | 0.31% | 100 |
|
|
2024
Q3 | $58.9M | Buy |
1,167,358
+49,733
| +4% | +$2.51M | 0.27% | 125 |
|
|
2024
Q2 | $49.1M | Buy |
1,117,625
+206,752
| +23% | +$9.09M | 0.24% | 136 |
|
|
2024
Q1 | $45.8M | Buy |
910,873
+298,823
| +49% | +$15M | 0.24% | 145 |
|
|
2023
Q4 | $37M | Buy |
612,050
+220,771
| +56% | +$13.3M | 0.22% | 161 |
|
|
2023
Q3 | $22.3M | Sell |
391,279
-18,840
| -5% | -$1.07M | 0.15% | 165 |
|
|
2023
Q2 | $20.9M | Buy |
+410,119
| New | +$20.9M | 0.13% | 170 |
|